Single-Agent Gemcitabine Is Active in Previously Treated Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|60|4|303-307

ISSN： 0030-2414

Source： Oncology, Vol.60, Iss.4, 2001-06, pp. : 303-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine plus Capecitabine Combination in Metastatic Breast Cancer Patients Previously Treated with Anthracyclines and Taxanes

By  

Oncology, Vol. 72, Iss. 5-6, 2008-01 ,pp. : 308-313

Karger

Access to resources Recommend Favorite

Is Gemcitabine plus Vinorelbine Active in Second-Line Chemotherapy of Metastatic Breast Cancer? A Single-Center Phase 2 Study

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 479-480

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine in Previously Untreated Elderly Patients with Advanced Bladder Carcinoma: Response to Treatment and Correlation with the Comprehensive Geriatric

By  

Oncology, Vol. 67, Iss. 1, 2004-10 ,pp. : 27-32

Karger

Access to resources Recommend Favorite

Phase II Study of Single-Agent Pegylated Liposomal Doxorubicin HCl (PLD) in Metastatic Breast Cancer After First-Line Treatment Failure

By  

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 441-446

Karger

Access to resources Recommend Favorite

Single-Agent Gemcitabine for Biliary Tract Cancers

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 358-365

Karger

Access to resources Recommend Favorite